Kim Sinyoung, Song Kyung Soon, Kim Hyun Ok, Lee Hwan Mo
Department of Laboratory Medicine, Yonsei University College of Medicine, C.P.O. Box 8044, Seoul 120-752, Korea.
Yonsei Med J. 2002 Jun;43(3):391-4. doi: 10.3349/ymj.2002.43.3.391.
There have been a few reported cases of immune hemolytic anemia induced by ceftriaxone. We encountered a patient with immune hemolytic anemia that seemed to be stimulated by a degradation product of ceftriaxone. The patient's direct antiglobulin test was positive only for C3d, and no ceftriaxone-dependent antibodies were detectable in the patient's serum. To demonstrate the presence of the ceftriaxone-induced antibodies, an ex-vivo antigen in urine was obtained from the patient. In addition, we prepared a 1 mg/mL suspension solution of ceftriaxone, and group AB serum as a complement source. Using several combinations of the above reactants, the indirect antiglobulin test was performed. Only the indirect antiglobulin test using the patient's serum with the ex-vivo urine antigen was found to be positive. Other combinations were not reactive. To our knowledge, this is the first reported case in Korea, in which the causative antibody appeared to be stimulated solely by a degradation product of ceftriaxone.
已有几例关于头孢曲松诱导的免疫性溶血性贫血的报道。我们遇到了一名免疫性溶血性贫血患者,其似乎是由头孢曲松的降解产物所激发。患者的直接抗球蛋白试验仅C3d呈阳性,且在患者血清中未检测到头孢曲松依赖性抗体。为证明头孢曲松诱导抗体的存在,从患者尿液中获取了体外抗原。此外,我们制备了1mg/mL的头孢曲松悬浮溶液,以及作为补体来源的AB型血清。使用上述反应物的几种组合进行了间接抗球蛋白试验。仅发现使用患者血清与体外尿液抗原进行的间接抗球蛋白试验呈阳性。其他组合无反应。据我们所知,这是韩国首例报道的病例,其中致病抗体似乎仅由头孢曲松的降解产物所激发。